About Us
Experience & trust built for 12 years
Sichuan Qingmu Pharmaceutical Co., Ltd., founded in May 2011, is a wholly-owned subsidiary of Chengdu Easton Biopharmaceuticals Co.,Ltd. (Sock code: 688513).
Qingmu is an innovation driven pharmaceutical company with primary strategic focus on the regulated market, the company speciallize in R&D and manufacturing of generic APIs and advanced intermediates, and also provides CDMO/CMO service for small molecule chemical drugs.
![Home](https://www.qingmupharm.com/wp-content/uploads/2023/06/629861282d8b5.jpg)
R & D
R & D Platform
Based on R&D concept “Green Chemistry “, Qingmu has gradually established key technical platforms such as asymmetric synthesis, transition metal catalysis (Cu, Fe, etc.), microchannel production, enzyme catalysis and drug crystallization process.
![Home](https://www.qingmupharm.com/wp-content/uploads/2023/06/z13.jpg)
Manufacturing
Manufacturing System
Policy: People-oriented, health and safety, energy conservation and environmental protection, pollution prevention, full participation, sustainable development